<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02966067</url>
  </required_header>
  <id_info>
    <org_study_id>DDUH2011/09/07</org_study_id>
    <nct_id>NCT02966067</nct_id>
  </id_info>
  <brief_title>A Split Mouth Trial to Compare Microneedles vs. Standard Needles in Dental Anaesthetic Delivery</brief_title>
  <official_title>A Split Mouth, Randomised Controlled Trial to Compare the Efficacy of an Array of 2x3 Pyramidal Microneedles of 280µm Height Versus a Standard 30-gauge Dental Needle in the Delivery of Local Anaesthetic Solution for Dental Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Dublin, Trinity College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tyndall National Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Dublin, Trinity College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will be completed as a two part, prospective, single-centre, randomised controlled&#xD;
      trial.&#xD;
&#xD;
      Five volunteers (dentists) will be recruited in the first part of the study to evaluate and&#xD;
      examine the microneedle device and its use. Based on those qualitative findings (individual&#xD;
      interviews and focus group) modifications to the microneedle device will be implemented&#xD;
      before part two of the study commences.&#xD;
&#xD;
      Twenty volunteers will be enrolled in the second part of the study. A split mouth design will&#xD;
      be used to compare the efficacy of an array of 2x3 pyramidal wet-etch silicone microneedles&#xD;
      of 280µm height with a standard 30-gauge short hypodermic needle in the delivery of local&#xD;
      dental anaesthetic solution. Quantitative and qualitative measurements of the pain&#xD;
      experienced and the depth of anaesthesia achieved will be recorded and compared.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be completed as a two part, prospective, single-centre, randomised controlled&#xD;
      trial.&#xD;
&#xD;
      Five volunteers (dentists) will be recruited in the first part of the study in order to&#xD;
      evaluate and examine the microneedle device and its use. Based on those qualitative findings&#xD;
      (individual interviews and focus group) modifications to the microneedle device will be&#xD;
      implemented before part two of the study commences.&#xD;
&#xD;
      Twenty healthy male volunteers will be invited to participate in the second part of the&#xD;
      study. Participants will be randomly assigned to receive a dental anaesthetic solution&#xD;
      injection with a microneedle device (Group I) or with a standard thirty-gauge short&#xD;
      hypodermic needles (Group II) in the first week of the second part of the study.&#xD;
&#xD;
      Group I: The microneedle device will be applied randomly to the left or right buccal mucosa&#xD;
      of the ﬁrst premolar tooth in the maxilla in order to inject slowly a standard local dental&#xD;
      anaesthetic solution.&#xD;
&#xD;
      Group II: A standard thirty-gauge short hypodermic needles will be used for insertion and&#xD;
      injection of the same standard local dental anaesthetic solution randomly to the left or&#xD;
      right buccal mucosa of the ﬁrst premolar tooth in the maxilla.&#xD;
&#xD;
      Quantitative and qualitative measurements of the pain experienced and the depth of&#xD;
      anaesthesia achieved will be recorded for both groups and compared.&#xD;
&#xD;
      In order to eliminate any carryover effects, a washout period of one week between receiving a&#xD;
      second, opposite injection will be applied (i.e. Group I will receive an injection with a&#xD;
      standard thirty-gauge short hypodermic needles and Group II an injection with the microneedle&#xD;
      device). The buccal mucosa of the ﬁrst premolar tooth in the untreated, opposite maxilla side&#xD;
      will receive an injection with the remaining injection method following the same procedure as&#xD;
      described for the first week.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Actual">December 8, 2017</completion_date>
  <primary_completion_date type="Actual">December 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Evaluation</measure>
    <time_frame>Immediately after injection of the anaesthetic</time_frame>
    <description>Discomfort / pain intensity rating will be recorded by using a visual analogue scale (VAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Experience</measure>
    <time_frame>Immediately after injection of the anaesthetic</time_frame>
    <description>Discomfort / pain experience will be recorded by using the Short-Form McGill Pain Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electronic Pulp Test</measure>
    <time_frame>15 minutes after injection</time_frame>
    <description>An electric pulp tester will be used to determine onset and duration of pulpal anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thermal Pulp Test</measure>
    <time_frame>10 minutes after injection</time_frame>
    <description>Dental refrigerant spray will be sprayed on a cotton pellet and then applied to determine onset and duration of pulpal anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pin-Prick Test</measure>
    <time_frame>2 minute intervals alternating with fine touch test until onset of soft tissue anaesthesia</time_frame>
    <description>Sensitivity of the buccal mucosa will be assessed with a spring algesimeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fine Touch Test</measure>
    <time_frame>2 minute intervals alternating with pin-prick test until onset of soft tissue anaesthesia</time_frame>
    <description>Von Frey hair fibres will be used to evaluate the soft tissue sensitivity to touch</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Dental Pain</condition>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>Microneedle Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Local Dental Anaesthetic Solution Delivery System: Microneedle device with an array of 2x3 pyramidal wet-etch silicone microneedles of 280µm height to inject anaesthetic solution.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30-gauge Short Hypodermic Needle</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local Dental Anaesthetic Solution Delivery System: Standard thirty-gauge short hypodermic needle to inject anaesthetic solution.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Microneedle Device (Experimental)</intervention_name>
    <description>Injection of 1.2ml of a standard local dental anaesthetic solution [1.2ml of 2% lidocaine and 1:80,000 epinephrine (lidocaine 20 mg/ml, epinephrine 12.5 mμ/ml)] at a rate of 1 mL/min.</description>
    <arm_group_label>Microneedle Device</arm_group_label>
    <other_name>Local Dental Anaesthetic Solution Delivery System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>30-gauge Short Hypodermic Needle</intervention_name>
    <description>Injection of 1.2ml of a standard local dental anaesthetic solution [1.2ml of 2% lidocaine and 1:80,000 epinephrine (lidocaine 20 mg/ml, epinephrine 12.5 mμ/ml)] at a rate of 1 mL/min.</description>
    <arm_group_label>30-gauge Short Hypodermic Needle</arm_group_label>
    <other_name>Local Dental Anaesthetic Solution Delivery System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        •Individuals are considered eligible for the study if they are not taking any medications&#xD;
        and are deemed competent to complete the McGill pain questionnaire short-form (MPQ-SF) and&#xD;
        visual analogue scale (VAS).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals will be excluded from the study if they suffer from the following&#xD;
             conditions:&#xD;
&#xD;
               -  Hypersensitivity to anaesthetics of the amide type&#xD;
&#xD;
               -  Epilepsy&#xD;
&#xD;
               -  Hypertension, impaired cardiac conduction&#xD;
&#xD;
               -  Impaired respiratory function&#xD;
&#xD;
               -  Impaired hepatic function&#xD;
&#xD;
               -  Cerebrovascular insufficiency&#xD;
&#xD;
               -  Thyrotoxicosis&#xD;
&#xD;
          -  Interventions not permitted during the study include the use of steroids, analgesics&#xD;
             or other non-steroidal inflammatory drugs and smoking.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darius Sagheri</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Dublin, Trinity College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ciarán P Devine</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Dublin, Trinity College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>June H Nunn</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Dublin, Trinity College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Erica Donnelly-Swift</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Dublin, Trinity College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Dublin, Trinity College</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>November 4, 2016</study_first_submitted>
  <study_first_submitted_qc>November 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2016</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Dublin, Trinity College</investigator_affiliation>
    <investigator_full_name>Darius Sagheri</investigator_full_name>
    <investigator_title>Director of Orthodontic Therapy</investigator_title>
  </responsible_party>
  <keyword>Microneedles</keyword>
  <keyword>Dental Anaesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Toothache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

